Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Verimatrix XTD gewinnt 2023 Global Infosec Award: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix XTD gewinnt 2023 Global Infosec Award


Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von benutzerorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass Verimatrix XTD (Extended

Verimatrix mit dem 2023 NAB Show „Produkt des Jahres"-Award ausgezeichnet: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix mit dem 2023 NAB Show „Produkt des Jahres"-Award ausgezeichnet


Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von benutzerorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass Verimatrix Streamkeeper mit

EQS-News: Abivax: Publication of an expert article in JCC on obefazimod as promising therapeutic management option for UC patients
EQS-News: Abivax: Publication of an expert article in JCC on obefazimod as promising therapeutic management option for UC patients
EQS-News: Abivax: Publication of an expert article in JCC on obefazimod as promising therapeutic management option for UC patients
Abivax postpones the publication of its 2023 Universal Registration Document
Abivax postpones the publication of its 2023 Universal Registration Document
Abivax postpones the publication of its 2023 Universal Registration Document
GEVELOT S.A.: Weekly report of share buyback April 26, 2023
GEVELOT S.A.: Weekly report of share buyback April 26, 2023
GEVELOT S.A.: Weekly report of share buyback April 26, 2023
RALLYE S.A.: Opening of ad hoc mandate proceedings  / Resumption of the listing of securities
RALLYE S.A.: Opening of ad hoc mandate proceedings / Resumption of the listing of securities
RALLYE S.A.: Opening of ad hoc mandate proceedings / Resumption of the listing of securities
Freelance.com: Annual earnings up sharply in 2022
Freelance.com: Annual earnings up sharply in 2022
Freelance.com: Annual earnings up sharply in 2022
EQS-News: Abivax reports 2022 financial results and operations update
EQS-News: Abivax reports 2022 financial results and operations update
EQS-News: Abivax reports 2022 financial results and operations update
Voyageurs du Monde: Business back at a high level and earnings growth
Voyageurs du Monde: Business back at a high level and earnings growth
Voyageurs du Monde: Business back at a high level and earnings growth
EQS-News: Abivax appoints Michael Ferguson as Chief Commerical Officer
EQS-News: Abivax appoints Michael Ferguson as Chief Commerical Officer
EQS-News: Abivax appoints Michael Ferguson as Chief Commerical Officer
EQS-News: Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
EQS-News: Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
EQS-News: Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2022 ACCOUNTS
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2022 ACCOUNTS
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2022 ACCOUNTS
Kaufman & Broad SA: 1ST QUARTER 2023 RESULTS
Kaufman & Broad SA: 1ST QUARTER 2023 RESULTS
Kaufman & Broad SA: 1ST QUARTER 2023 RESULTS
Kaufman & Broad SA: AVAILABILITY OF THE PREPARATORY DOCUMENTS FOR THE COMBINED ORDINARY AND EXTRAORDINARY GENERAL MEETING OF MAY 4, 2023
Kaufman & Broad SA: AVAILABILITY OF THE PREPARATORY DOCUMENTS FOR THE COMBINED ORDINARY AND EXTRAORDINARY GENERAL MEETING OF MAY 4, 2023
Kaufman & Broad SA: AVAILABILITY OF THE PREPARATORY DOCUMENTS FOR THE COMBINED ORDINARY AND EXTRAORDINARY GENERAL MEETING OF MAY 4, 2023
PATRIMOINE ET COMMERCE: Q1 2023 RESULTS
PATRIMOINE ET COMMERCE: Q1 2023 RESULTS
PATRIMOINE ET COMMERCE: Q1 2023 RESULTS
EQS-News: Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
EQS-News: Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
EQS-News: Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
Kaufman & Broad SA: AVAILABILITY OF THE  2022 UNIVERSAL REGISTRATION DOCUMENT
Kaufman & Broad SA: AVAILABILITY OF THE 2022 UNIVERSAL REGISTRATION DOCUMENT
Kaufman & Broad SA: AVAILABILITY OF THE 2022 UNIVERSAL REGISTRATION DOCUMENT
Transgene Announces Upcoming Investor Meetings: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene Announces Upcoming Investor Meetings


Regulatory News:



TRANSGENE (Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces that Management will participate in

Linedata Confirms Commitment to APAC Region With New Office in Singapore: https://mms.businesswire.com/media/20211107005124/en/924432/5/Linedata_Logo.jpg
Linedata Confirms Commitment to APAC Region With New Office in Singapore


Linedata (Euronext Paris: LIN), a global provider of credit and asset management technology, data and services, announces today the opening of its new office in Singapore, strengthening its

ESI Group feiert ihr 50-jähriges Jubiläum mit einem klaren Rebranding und schlägt ein neues Kapitel der Unternehmensgeschichte auf: https://mms.businesswire.com/media/20210510005423/de/877137/5/2020_11_04_MKTG_ESI_Logo_ColorTagline_rgb.jpg
ESI Group feiert ihr 50-jähriges Jubiläum mit einem klaren Rebranding und schlägt ein neues Kapitel der Unternehmensgeschichte auf


Die ESI Group (ISIN-Code: FR0004110310, Tickersymbol: ESI), der weltweit anerkannte Software-Anbieter für Simulation und Virtual Prototyping für die Industrie, kündigt anlässlich ihres 50-jährigen

ESI Group Reveals Bold Rebranding to Celebrate 50 Years and Marks the Beginning of a Next Chapter: https://mms.businesswire.com/media/20210510005423/de/877137/5/2020_11_04_MKTG_ESI_Logo_ColorTagline_rgb.jpg
ESI Group Reveals Bold Rebranding to Celebrate 50 Years and Marks the Beginning of a Next Chapter


Regulatory News:



ESI Group (ISIN Code: FR0004110310, Symbol: ESI), the world-renowned simulation and virtual prototyping software provider for the industry, announces a dynamic new brand identity

Poxel Announces Cash Runway Extended Through Q2 2025 Based upon Debt Restructuring Agreement and New Equity-linked Financing Facility: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces Cash Runway Extended Through Q2 2025 Based upon Debt Restructuring Agreement and New Equity-linked Financing Facility


Regulatory News:



POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic

Poxel Reports Financial Results for Full Year 2022 and Provides Corporate Update: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Reports Financial Results for Full Year 2022 and Provides Corporate Update


Regulatory News:



POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic

Poxel will Report its 2022 Full Year Results on March 23, 2023: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel will Report its 2022 Full Year Results on March 23, 2023


Regulatory News:



POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic

RALLYE S.A.: Annual results 2022
RALLYE S.A.: Annual results 2022
RALLYE S.A.: Annual results 2022